Vir Biotechnology, Inc. Insider Trading for October 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vir Biotechnology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Vir Biotechnology, Inc. for October 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 22 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Option Exercise | M | 5.18 | 2,315 | 11,980 | 67,129 | |
Oct 22 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Option Exercise | M | 1.58 | 2,315 | 3,646 | 48,612 | |
Oct 22 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Option Exercise | M | 1.53 | 7,870 | 12,041 | 92,591 | |
Oct 22 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Sell | S | 35.59 | 5,000 | 177,952 | 29,777 | 34.8 K to 29.8 K (-14.38 %) |
Oct 22 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Sell | S | 35.42 | 7,500 | 265,657 | 34,777 | 42.3 K to 34.8 K (-17.74 %) |
Oct 22 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Buy | M | 5.18 | 2,315 | 11,980 | 42,277 | 40 K to 42.3 K (+5.79 %) |
Oct 22 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Buy | M | 1.58 | 2,315 | 3,646 | 39,962 | 37.6 K to 40 K (+6.15 %) |
Oct 22 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Buy | M | 1.53 | 7,870 | 12,041 | 37,647 | 29.8 K to 37.6 K (+26.43 %) |
Oct 14 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 5,560 | 8,507 | 454,315 | |
Oct 14 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Sell | S | 43.03 | 5,560 | 239,236 | 23,700 | 29.3 K to 23.7 K (-19.00 %) |
Oct 14 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 5,560 | 8,507 | 29,260 | 23.7 K to 29.3 K (+23.46 %) |
Oct 14 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 5,560 | 8,507 | 454,315 | |
Oct 14 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Sell | S | 43.03 | 5,560 | 239,236 | 23,700 | 29.3 K to 23.7 K (-19.00 %) |
Oct 14 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 5,560 | 8,507 | 29,260 | 23.7 K to 29.3 K (+23.46 %) |
Oct 08 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Option Exercise | M | 1.58 | 2,315 | 3,646 | 50,927 | |
Oct 08 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Option Exercise | M | 1.53 | 10,185 | 15,583 | 100,461 | |
Oct 08 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Sell | S | 41.73 | 5,000 | 208,629 | 29,777 | 34.8 K to 29.8 K (-14.38 %) |
Oct 08 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Sell | S | 41.76 | 7,500 | 313,166 | 34,777 | 42.3 K to 34.8 K (-17.74 %) |
Oct 08 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Buy | M | 1.58 | 2,315 | 3,646 | 42,277 | 40 K to 42.3 K (+5.79 %) |
Oct 08 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Buy | M | 1.53 | 10,185 | 15,583 | 39,962 | 29.8 K to 40 K (+34.20 %) |
Oct 02 2020 | VIR | Vir Biotechnology, ... | Parrish Jay | Chief Business Offi ... | Option Exercise | M | 1.58 | 2,315 | 3,646 | 50,926 | |
Oct 02 2020 | VIR | Vir Biotechnology, ... | Parrish Jay | Chief Business Offi ... | Option Exercise | M | 1.49 | 4,630 | 6,876 | 32,407 | |
Oct 02 2020 | VIR | Vir Biotechnology, ... | Parrish Jay | Chief Business Offi ... | Sell | S | 34.75 | 6,945 | 241,342 | 222,222 | 229.2 K to 222.2 K (-3.03 %) |
Oct 02 2020 | VIR | Vir Biotechnology, ... | Parrish Jay | Chief Business Offi ... | Buy | M | 1.58 | 2,315 | 3,646 | 229,167 | 226.9 K to 229.2 K (+1.02 %) |
Oct 02 2020 | VIR | Vir Biotechnology, ... | Parrish Jay | Chief Business Offi ... | Buy | M | 1.49 | 4,630 | 6,876 | 226,852 | 222.2 K to 226.9 K (+2.08 %) |
Oct 01 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 3,510 | 5,370 | 459,875 | |
Oct 01 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Sell | S | 38.00 | 3,510 | 133,380 | 23,700 | 27.2 K to 23.7 K (-12.90 %) |
Oct 01 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 3,510 | 5,370 | 27,210 | 23.7 K to 27.2 K (+14.81 %) |